Tag: Prescription Drugs
Upping Dose May Aid Smoking Cessation After Initial Treatment Failure
Benefit seen with additional six weeks of treatment after six weeks of initial failure with varenicline or nicotine replacement
Elimination of Buprenorphine Waiver Had Moderate Effect
Significant increase seen in monthly number of buprenorphine prescribers, but modest increase seen in number of patients receiving buprenorphine
Seven Percent of Outpatients Experience One or More Adverse Event
Overall, 23.2 percent of adverse events are preventable; 17.2 percent are serious
Chronic Hepatitis B Virus Is Undertreated
Findings seen in global study of patients in nine countries
Cabozantinib Promising for Metastatic Pheochromocytomas, Paragangliomas
Overall response rate was 25.0 percent in phase 2 study involving 17 patients
Cabozantinib Promising for Advanced Adrenocortical Carcinoma
Promising efficacy seen with a manageable safety profile in phase 2 study involving 18 patients
AI May Be Useful in Polypharmacy Management
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
Antihypertensive Meds Initiation Linked to Fractures in Nursing Home Seniors
Antihypertensive medication initiation also linked to higher risk for severe falls requiring hospitalization, ED visits
Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer
Disease-free survival benefit was consistent with that seen in previous analyses; improvement in overall survival also seen
Erenumab Effective, Safe for Rosacea-Linked Erythema, Flushing
Reduction seen in mean number of days with moderate-to-extreme flushing, moderate-to-severe erythema
